137 studies found for:    IPF | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
2 Recruiting Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
3 Not yet recruiting CleanUP IPF for the Pulmonary Trials Cooperative
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Antimicrobial therapy: Co-trimoxazole or Doxycycline;   Other: No Intervention: Standard of Care
4 Recruiting Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis
Condition: Ambulatory IPF
Interventions: Drug: Rituximab;   Drug: Placebo
5 Recruiting Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
6 Not yet recruiting Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Yoga
7 Recruiting High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Other: 60% Oxygen;   Other: Standard of Care
8 Recruiting Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   IPF
Interventions: Drug: tipelukast;   Drug: Placebo
9 Recruiting Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Behavioral: Physical exercise training;   Behavioral: Cognitive exercise training
10 Recruiting Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention: Drug: Dasatinib + Quercetin
11 Recruiting Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention:
12 Not yet recruiting A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Valganciclovir;   Drug: Placebo
13 Recruiting The Predictive Ability of 4MGS in IPF
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: 4MGS
14 Recruiting PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
15 Recruiting Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Pirfenidone
16 Recruiting STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Interventions: Drug: BG00011;   Drug: Placebo
17 Recruiting All-Case Surveillance of Ofev in Patients With IPF in Japan
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Nintedanib
18 Recruiting Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Omeprazole;   Drug: Matched placebo
19 Recruiting Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Nintedanib;   Drug: Pirfenidone
20 Recruiting Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.